STRATA Skin Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SSKN research report →
About the company
STRATA Skin Sciences, Inc. is an innovative medical technology enterprise dedicated to the development, commercialization, and marketing of advanced products specifically designed for treating a range of dermatologic conditions. The company operates through two main divisions: Dermatology Recurring Procedures and Dermatology Procedures Equipment.
- CEO
- Dolev Rafaeli
- IPO
- 2005
- Employees
- 106
- HQ
- Horsham, PA, US
Price Chart
- Market Cap
- $604.53K
- P/E
- -0.13
- P/S
- 0.02
- P/B
- 0.26
- EV/EBITDA
- -15.89
- Div Yield
- 0.00%
- Gross Margin
- 57.83%
- Op Margin
- -19.74%
- Net Margin
- -21.13%
- ROE
- -360.33%
- ROIC
- -31.30%
- Revenue
- $30.70M · -8.54%
- Net Income
- $-6,261,000 · 37.92%
- EPS
- $-1.35 · -419.23%
- Op Income
- $-5,835,000
- FCF YoY
- -194.34%
- 52W High
- $3.86
- 52W Low
- $0.10
- 50D MA
- $0.14
- 200D MA
- $0.87
- Beta
- -0.05
- Avg Volume
- 13.62K
Get TickerSpark's AI analysis on SSKN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 25 | Rubinstein Samuel | sell | 5,500 |
| Nov 18, 25 | Rubinstein Samuel | buy | 2,832 |
| Nov 18, 25 | Rubinstein Samuel | buy | 2,168 |
| Nov 17, 25 | Rubinstein Samuel | sell | 7,200 |
| Nov 17, 25 | Rubinstein Samuel | sell | 1,394 |
| May 13, 25 | Gov Shmuel | other | 40,000 |
| May 13, 25 | Gillings John T | other | 30,000 |
| May 13, 25 | Rafaeli Dolev | other | 58,000 |
| Nov 13, 24 | Gillings John T | other | 0 |
| Oct 29, 24 | Allgeier Christina L | other | 20,000 |
Our SSKN coverage
Recent articles, reports, and earnings notes.
No research on SSKN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SSKN report →Similar companies
Peers in the same neighborhood.